You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 9, September 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Machado-Joseph-Azorean Disease

A Ten-Year Study

Hilton L. Fowler, MD

Arch Neurol. 1984;41(9):921-925.


Abstract

• In a ten-year study of Machado-Joseph-Azorean disease (MJAD), three distinct syndromes emerged: ataxia syndrome (11 patients), ataxia-motor neuron syndrome (four), and ataxia-motor neuron-extrapyramidal syndrome (two). Three patients had such advanced disease that classification was not possible. These syndromes more accurately describe functional deficits than did previous classifications. Spread of neuronal degeneration from the cerebellar system to the motor neurons of the spinal cord and brain stem was found for the first time, to my knowledge, in five patients and to the motor neurons and the extrapyramidal system in two of 14 patients followed up. There is no dementia, and peripheral neuropathy is a late complication common to all syndromes. World presence of MJAD could have begun with Portuguese overseas expansion in 1415. Alternatively, the possibility of multiple spontaneous mutations must be considered. Genetic sameness depends on a specific genetic marker, which is not yet available. For accurate genetic counseling, a nonspecific biologic marker for this disease is sought, and electronystagmography changes may prove helpful. This is particularly important as this illness, like Huntington's disease, is usually not manifest until the child-bearing years or after.



Author Affiliations

From the Neurology Service, Veterans Administration Medical Center, Hampton, Va; and the Department of Neurology, Eastern Virginia Medical School, Norfolk.


Footnotes

Accepted for publication Jan 6, 1984.

Reprint requests to Neurology Service, VA Medical Center, Hampton, VA 23667 (Dr Fowler).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17)
Lasek et al.
Brain 2006;129:2341-2352.
ABSTRACT | FULL TEXT  

A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration
Goti et al.
J. Neurosci. 2004;24:10266-10279.
ABSTRACT | FULL TEXT  

Hereditary Spastic Paraplegia and Hereditary Ataxia: Part 2: A Family Demonstrating Various Phenotypic Manifestations With the SCA3 Genotype
Landau et al.
Arch Neurol 2000;57:733-739.
ABSTRACT | FULL TEXT  

Family With Dominantly Inherited Ataxia, Amyotrophy, and Peripheral Sensory Loss: Spinopontine Atrophy or Machado-Joseph Azorean Disease in Another Non-Portuguese Family?
Eto et al.
Arch Neurol 1990;47:968-974.
ABSTRACT  

Machado-Joseph-Azorean Disease in India
Bharucha et al.
Arch Neurol 1986;43:142-144.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.